Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.10.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement        
Revenues
Operating Costs and Expenses        
Research and development expense 79,003 98,904 190,223 196,096
General and administrative expenses 155,128 177,435 279,780 368,169
Total operating costs and expenses 234,131 276,339 470,003 564,265
Income (loss) from operations (234,131) (276,339) (470,003) (564,265)
Other Income and Expenses        
Interest expense 288,693 112,952 637,684 187,423
Change in fair value of embedded derivative 2,000 44,000 120,000 54,000
Gain (loss) on extinguishment of debt (91,621)   (91,621)  
Gain (loss) on extinguishment of debentures 43,829   43,829  
Total other income and (expenses) (334,485) (68,952) (565,476) (133,423)
Net income (loss) $ (568,616) $ (345,291) $ (1,035,479) $ (697,688)
Basic and diluted earnings (loss) per share $ (0.01) $ (0.01) $ (0.02) $ (0.03)
Weighted average common shares outstanding - basic and diluted 58,430,000 27,284,000 55,745,000 27,145,000